Rising antiparasitic drug cost in U.S. leads to higher patient costs, decreased quality of care

New study finds the skyrocketing cost of drugs in U.S. used to treat hookworm and other soil-transmitted parasites increases patient costs, suggests decreased quality of care A new study finds that the increasingly high prices in the United States of the drugs used to treat three soil-transmitted helminth infections—hookworm, roundworm (ascariasis), and whipworm (trichuriasis)—is not only the major driver for […]

Read more